NEWS HIGHLIGHT:

Parexel and Signify Health Collaborating to Develop New Solutions to Promote Access and Inclusion in Clinical Trials

Read More

 

Press Releases

 

In the News

 

Latest Podcasts

The Parexel Podcast | Episode 14: Why Parents and Children Join Research Studies: CISCRP’s 2020 Pediatric Perceptions & Insights Survey Reveals Critical Insights

Pediatric participation in clinical trials is essential to understanding how drugs perform in children, whose side effects and responses to medications are often very different from adults. Yet the vast majority of medications are only evaluated in adults, and pediatric participation in clinical trials remains exceedingly low worldwide. In this podcast, experts discuss critical insights gleaned from a survey of 500 parents and children about their perceptions and experiences of clinical research.

Episode 13: The New Pragmatism: Clinical Trials, Investment and Regulations Post-COVID-19

Once the COVID-19 pandemic passes or is contained, the world will look and work very differently. The biopharmaceutical industry is no exception. In this podcast, Peyton Howell, Parexel’s Chief Commercial and Strategy Officer, talks with Paul Bridges, Worldwide Head of Regulatory and Access, and Sheela Hegde, a Partner with Parexel’s Health Advances subsidiary, about the regulatory, investing and clinical development changes that are most likely here to stay – The New Pragmatism.

The Parexel Podcast | Episode 12: ASCO20 Debrief: The latest in cell and gene therapy

In this podcast, clinical industry experts discuss the progress made in cell and gene therapy as presented at ASCO and how the industry can continue to move these developments forward today and in the future.

Awards & Achievements

Media Resources & Contacts

 

Lori Dorer

Vice President, Executive & Strategic Communications

T: 978.495.4135
M: 513.496.8121
E: Lori.Dorer@parexel.com

Becky Levine

Associate Director, Global Public Relations

T: 919.748.6090
M: 919.271.5151
E: Becky.Levine@parexel.com

We are always available for a conversation.

*